UiPath Target of Unusually High Options Trading (NYSE:PATH)

Posted by Defense World Staff on May 23rd, 2023

UiPath Inc. (NYSE:PATH – Get Rating) was the recipient of unusually large options trading on Monday. Stock investors bought 10,314 call options on the company. This represents an increase of 77% compared to the average daily volume of 5,827 call options.

Insider Buying and Selling

In related news, CAO Hitesh Ramani sold 12,000 shares of the company’s stock in a transaction on Friday, March 17th. The stock was sold at an average price of $17.01, for a total transaction of $204,120.00. Following the completion of the transaction, the chief accounting officer now directly owns 407,349 shares in the company, valued at approximately $6,929,006.49. The sale was disclosed in a document filed with the SEC, which is available through this link. In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the business’s stock in a transaction on Friday, March 17th. The stock was sold at an average price of $16.96, for a total transaction of $678,400.00. Following the completion of the transaction, the chief financial officer now owns 1,319,051 shares in the company, valued at approximately $22,371,104.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Hitesh Ramani sold 12,000 shares of the company’s stock in a transaction on Friday, March 17th. The shares were sold at an average price of $17.01, for a total value of $204,120.00. Following the completion of the sale, the chief accounting officer now owns 407,349 shares of the company’s stock, valued at approximately $6,929,006.49. The disclosure for this sale can be found here. Insiders sold a total of 92,000 shares of company stock worth $1,529,720 in the last three months. 31.88% of the stock is owned by insiders.

Institutional Trading of UiPath

Large investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of UiPath during the 1st quarter worth about $27,000. Manchester Capital Management LLC bought a new stake in shares of UiPath during the 1st quarter worth about $31,000. Sonnipe Ltd bought a new stake in shares of UiPath during the 4th quarter worth about $26,000. U.S. Capital Wealth Advisors LLC bought a new stake in shares of UiPath during the 4th quarter worth about $26,000. Finally, Quarry LP bought a new stake in shares of UiPath during the 1st quarter worth about $36,000. Institutional investors own 56.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on PATH. DA Davidson began coverage on UiPath in a report on Thursday, April 20th. They issued a “neutral” rating and a $16.00 price objective for the company. Credit Suisse Group restated an “outperform” rating and issued a $27.50 price objective on shares of UiPath in a report on Friday, March 17th. TD Cowen upped their price objective on UiPath from $20.00 to $22.00 and gave the company an “outperform” rating in a report on Monday, April 3rd. Mizuho boosted their target price on UiPath from $15.00 to $16.00 in a research report on Thursday, March 16th. Finally, Royal Bank of Canada boosted their target price on UiPath from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research report on Wednesday, March 29th. Eight equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, UiPath currently has an average rating of “Hold” and an average price target of $19.03.

UiPath Price Performance

Shares of PATH stock opened at $16.63 on Tuesday. UiPath has a fifty-two week low of $10.40 and a fifty-two week high of $22.30. The stock’s 50-day moving average is $15.48 and its two-hundred day moving average is $14.33. The firm has a market cap of $9.27 billion, a P/E ratio of -27.72 and a beta of 0.69.

UiPath (NYSE:PATH – Get Rating) last issued its earnings results on Wednesday, March 15th. The healthcare company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. UiPath had a negative return on equity of 15.38% and a negative net margin of 31.02%. The company had revenue of $308.55 million for the quarter, compared to analyst estimates of $278.14 million. As a group, research analysts expect that UiPath will post -0.33 EPS for the current year.

UiPath Company Profile

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.